Table 5:

Mixed models analysis correlating proportion of infants with failed NBHS who underwent CMV testing to factors involved in early CMV screening:

Protocol characteristic (present vs. not)	Odds Ratio (OR) (95% Confidence Interval)	p-value
Nurse facilitates cCMV testing	5.9 (3.4, 10.2)	< 0.001
PCP orders cCMV testing	5.4 (3.1, 9.2)	<0.001
Conditional cCMV test order set	5.3 (3.2, 8.7)	< 0.001
Provider contacting for cCMV+ test:
Neonatologist	3.7 (2.2, 6.0)	< 0.001
Primary care	0.2 (0.1, 0.3)	< 0.001
Audiologist	2.9 (1.22, 6.75)	0.015
Other	0.3 (0.2, 0.5)	< 0.001
Diagnostic testing after cCMV+ test:
Head US	20.8 (13.6, 31.5)	< 0.001
CMP	0.8 (0.6, 1.1)	0.14
Head ultrasound ordered if cCMV positive test result	20.8 (13.6, 31.5)	< 0.001
A Multidisciplinary team involved in cCMV evaluation and treatment	18.7 (6.0, 58.3)	< 0.001
Process to contact cCMV+ infants LTFU	8.4 (6.7, 10.6)	< 0.001
Track cCMV+ patient symptoms	0.26 (0.13, 0.50)	< 0.001

cCMV = congenital CMV; cCMV+ = positive congenital CMV test; Head US = head ultrasound; CMP = complete metabolic panel; LTFU = lost to follow-up